Gilead's remdesivir shows promise in COVID-19 study on monkeys
The Jerusalem Post
Remdesivir is the first drug to show improvement in COVID-19 in human trials, and its progress in clinical studies is being closely watched as nations look for a treatment for the disease.
https://www.jpost.com/health-science/gileads-remdesivir-shows-promise-in-covid-19-study-on-monkeys-630841